Target of the Week - ALK Antibodies

|
Dear Cancer Researcher, Abgent offers a portfolio of antibodies for the detection of ALK in western blotting, immunohistochemistry and immunofluorescence. ALK kinase is involved in the MAPK-pathway which contributes to cell proliferation induction and cancers such as inflammatory myofibroblastic tumors (IMTs), anaplastic large-cell lymphoma (ALCL), and adenocarcinoma. One of Abgent’s ALK antibodies was cited recently in Toxicol. Sci. 2015 Jan;143(1):116-25. To find the right antibody for your research, please visit Abgent ALK Antibodies. |
Polyclonal ALK AntibodyCat# AP7600a |
Polyclonal ALK AntibodyCat# AP7600b |
Polyclonal ALK AntibodyCat# AP7600c |
Phospho-ALK AntibodyCat# AP50572 |
![]() |
![]() |
![]() |






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.


